nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—HTR1A—schizophrenia	0.507	0.625	CbGaD
Alprenolol—CYP2D6—schizophrenia	0.304	0.375	CbGaD
Alprenolol—HTR1A—telencephalic ventricle—schizophrenia	0.00357	0.181	CbGeAlD
Alprenolol—CYP2D6—urine—schizophrenia	0.00177	0.0898	CbGeAlD
Alprenolol—HTR1A—blood plasma—schizophrenia	0.0017	0.0864	CbGeAlD
Alprenolol—ADRB1—forebrain—schizophrenia	0.00109	0.0552	CbGeAlD
Alprenolol—ADRB1—telencephalon—schizophrenia	0.000998	0.0507	CbGeAlD
Alprenolol—HTR1A—forebrain—schizophrenia	0.000931	0.0473	CbGeAlD
Alprenolol—CYP2D6—blood plasma—schizophrenia	0.000923	0.0469	CbGeAlD
Alprenolol—HTR1A—telencephalon—schizophrenia	0.000856	0.0435	CbGeAlD
Alprenolol—Penbutolol—HTR1B—schizophrenia	0.000829	0.119	CrCbGaD
Alprenolol—Penbutolol—HTR1A—schizophrenia	0.000656	0.0941	CrCbGaD
Alprenolol—ADRB1—endocrine gland—schizophrenia	0.00063	0.032	CbGeAlD
Alprenolol—HTR1A—midbrain—schizophrenia	0.000615	0.0312	CbGeAlD
Alprenolol—Pindolol—HTR1B—schizophrenia	0.000598	0.0857	CrCbGaD
Alprenolol—ADRB1—nervous system—schizophrenia	0.000589	0.0299	CbGeAlD
Alprenolol—ADRB1—central nervous system—schizophrenia	0.000567	0.0288	CbGeAlD
Alprenolol—HTR1A—endocrine gland—schizophrenia	0.00054	0.0274	CbGeAlD
Alprenolol—Betaxolol—CYP1A2—schizophrenia	0.000515	0.0738	CrCbGaD
Alprenolol—CYP2D6—forebrain—schizophrenia	0.000506	0.0257	CbGeAlD
Alprenolol—HTR1A—nervous system—schizophrenia	0.000506	0.0257	CbGeAlD
Alprenolol—HTR1A—central nervous system—schizophrenia	0.000487	0.0247	CbGeAlD
Alprenolol—HTR1A—cerebellum—schizophrenia	0.000476	0.0242	CbGeAlD
Alprenolol—Pindolol—HTR1A—schizophrenia	0.000473	0.0678	CrCbGaD
Alprenolol—CYP2D6—telencephalon—schizophrenia	0.000465	0.0236	CbGeAlD
Alprenolol—ADRB1—brain—schizophrenia	0.00045	0.0229	CbGeAlD
Alprenolol—Betaxolol—CYP2D6—schizophrenia	0.000397	0.0569	CrCbGaD
Alprenolol—HTR1A—brain—schizophrenia	0.000386	0.0196	CbGeAlD
Alprenolol—Bisoprolol—CYP2D6—schizophrenia	0.000384	0.055	CrCbGaD
Alprenolol—Acebutolol—CYP2D6—schizophrenia	0.000363	0.0521	CrCbGaD
Alprenolol—Oxprenolol—CYP2D6—schizophrenia	0.000361	0.0517	CrCbGaD
Alprenolol—CYP2D6—blood—schizophrenia	0.000338	0.0172	CbGeAlD
Alprenolol—Propranolol—HTR1B—schizophrenia	0.000326	0.0467	CrCbGaD
Alprenolol—Metoprolol—CYP2D6—schizophrenia	0.000307	0.044	CrCbGaD
Alprenolol—CYP2D6—endocrine gland—schizophrenia	0.000293	0.0149	CbGeAlD
Alprenolol—Pindolol—CYP2D6—schizophrenia	0.000284	0.0407	CrCbGaD
Alprenolol—Atenolol—ABCB1—schizophrenia	0.000281	0.0403	CrCbGaD
Alprenolol—CYP2D6—nervous system—schizophrenia	0.000274	0.0139	CbGeAlD
Alprenolol—CYP2D6—central nervous system—schizophrenia	0.000264	0.0134	CbGeAlD
Alprenolol—Acebutolol—ABCB1—schizophrenia	0.000259	0.0372	CrCbGaD
Alprenolol—CYP2D6—cerebellum—schizophrenia	0.000258	0.0131	CbGeAlD
Alprenolol—Propranolol—HTR1A—schizophrenia	0.000258	0.037	CrCbGaD
Alprenolol—Metoprolol—ABCB1—schizophrenia	0.000219	0.0314	CrCbGaD
Alprenolol—CYP2D6—brain—schizophrenia	0.00021	0.0107	CbGeAlD
Alprenolol—Propranolol—CYP1A2—schizophrenia	0.000201	0.0288	CrCbGaD
Alprenolol—Propranolol—CYP2D6—schizophrenia	0.000155	0.0222	CrCbGaD
Alprenolol—Propranolol—ABCB1—schizophrenia	0.000111	0.0158	CrCbGaD
Alprenolol—ADRB3—Signaling Pathways—NPS—schizophrenia	4.16e-05	0.000258	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR1A—schizophrenia	4.15e-05	0.000257	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD4—schizophrenia	4.15e-05	0.000257	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR6—schizophrenia	4.14e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GRM3—schizophrenia	4.13e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RTN4—schizophrenia	4.13e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RGS4—schizophrenia	4.13e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2C—schizophrenia	4.1e-05	0.000254	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD1—schizophrenia	4.1e-05	0.000254	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—NPS—schizophrenia	4.09e-05	0.000253	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD1—schizophrenia	4.08e-05	0.000253	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2C—schizophrenia	4.08e-05	0.000253	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLCH2—schizophrenia	4.08e-05	0.000253	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD4—schizophrenia	4.06e-05	0.000252	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CNR1—schizophrenia	4.05e-05	0.000251	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR6—schizophrenia	4.05e-05	0.000251	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GRM3—schizophrenia	4.04e-05	0.00025	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RTN4—schizophrenia	4.04e-05	0.00025	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RGS4—schizophrenia	4.04e-05	0.00025	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2C—schizophrenia	4.01e-05	0.000248	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD1—schizophrenia	4.01e-05	0.000248	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—NPS—schizophrenia	4e-05	0.000248	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAG—schizophrenia	4e-05	0.000248	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD3—schizophrenia	3.97e-05	0.000246	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NTRK2—schizophrenia	3.97e-05	0.000246	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CNR1—schizophrenia	3.97e-05	0.000246	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR6—schizophrenia	3.96e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD2—schizophrenia	3.96e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR7—schizophrenia	3.96e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD3—schizophrenia	3.95e-05	0.000245	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2C—schizophrenia	3.92e-05	0.000243	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD1—schizophrenia	3.92e-05	0.000243	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAG—schizophrenia	3.91e-05	0.000242	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD3—schizophrenia	3.89e-05	0.000241	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CNR1—schizophrenia	3.88e-05	0.00024	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR7—schizophrenia	3.87e-05	0.00024	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD2—schizophrenia	3.87e-05	0.00024	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD4—schizophrenia	3.86e-05	0.000239	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD4—schizophrenia	3.84e-05	0.000238	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NDST3—schizophrenia	3.84e-05	0.000238	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAG—schizophrenia	3.83e-05	0.000237	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD3—schizophrenia	3.8e-05	0.000235	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR7—schizophrenia	3.78e-05	0.000234	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD2—schizophrenia	3.78e-05	0.000234	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD4—schizophrenia	3.77e-05	0.000234	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD4—schizophrenia	3.69e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CNR1—schizophrenia	3.68e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CNR1—schizophrenia	3.66e-05	0.000227	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CHRM1—schizophrenia	3.66e-05	0.000227	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC27A5—schizophrenia	3.64e-05	0.000225	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ACSL6—schizophrenia	3.64e-05	0.000225	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CNR1—schizophrenia	3.6e-05	0.000223	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD2—schizophrenia	3.59e-05	0.000222	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR7—schizophrenia	3.59e-05	0.000222	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CHRM1—schizophrenia	3.58e-05	0.000222	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD2—schizophrenia	3.58e-05	0.000221	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR7—schizophrenia	3.58e-05	0.000221	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL3RA—schizophrenia	3.56e-05	0.000221	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CNR1—schizophrenia	3.52e-05	0.000218	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD2—schizophrenia	3.51e-05	0.000218	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR7—schizophrenia	3.51e-05	0.000218	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CHRM1—schizophrenia	3.5e-05	0.000217	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL3RA—schizophrenia	3.49e-05	0.000216	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TLE1—schizophrenia	3.48e-05	0.000215	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NRG3—schizophrenia	3.48e-05	0.000215	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DAO—schizophrenia	3.47e-05	0.000215	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GFAP—schizophrenia	3.44e-05	0.000213	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR7—schizophrenia	3.44e-05	0.000213	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD2—schizophrenia	3.44e-05	0.000213	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL3RA—schizophrenia	3.41e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NRG3—schizophrenia	3.4e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TLE1—schizophrenia	3.4e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GRM5—schizophrenia	3.4e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PRL—schizophrenia	3.38e-05	0.000209	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GFAP—schizophrenia	3.36e-05	0.000208	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NRG3—schizophrenia	3.33e-05	0.000206	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TLE1—schizophrenia	3.33e-05	0.000206	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GRM5—schizophrenia	3.33e-05	0.000206	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PNP—schizophrenia	3.33e-05	0.000206	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TLE3—schizophrenia	3.29e-05	0.000204	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GFAP—schizophrenia	3.29e-05	0.000204	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GRM5—schizophrenia	3.25e-05	0.000201	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TLE3—schizophrenia	3.22e-05	0.0002	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TLE3—schizophrenia	3.15e-05	0.000195	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—S100B—schizophrenia	3.15e-05	0.000195	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCK—schizophrenia	3.11e-05	0.000193	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NDUFV2—schizophrenia	3.09e-05	0.000191	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCK—schizophrenia	3.04e-05	0.000188	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDE4B—schizophrenia	3.03e-05	0.000188	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ERBB4—schizophrenia	3.01e-05	0.000186	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCKAR—schizophrenia	2.98e-05	0.000185	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCK—schizophrenia	2.97e-05	0.000184	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDE4B—schizophrenia	2.96e-05	0.000184	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCKAR—schizophrenia	2.92e-05	0.000181	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIP4K2A—schizophrenia	2.91e-05	0.00018	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDE4B—schizophrenia	2.9e-05	0.00018	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADORA2A—schizophrenia	2.89e-05	0.000179	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCKAR—schizophrenia	2.85e-05	0.000177	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PLA2G4A—schizophrenia	2.84e-05	0.000176	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PLA2G4A—schizophrenia	2.83e-05	0.000175	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	2.83e-05	0.000175	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	2.78e-05	0.000172	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NRG1—schizophrenia	2.78e-05	0.000172	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGA—schizophrenia	2.77e-05	0.000172	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—schizophrenia	2.77e-05	0.000172	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADORA2A—schizophrenia	2.77e-05	0.000171	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MEF2C—schizophrenia	2.75e-05	0.00017	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PLA2G4A—schizophrenia	2.72e-05	0.000168	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGA—schizophrenia	2.71e-05	0.000168	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	2.71e-05	0.000168	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NPY—schizophrenia	2.7e-05	0.000167	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ATP2A2—schizophrenia	2.7e-05	0.000167	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH4—schizophrenia	2.7e-05	0.000167	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—YWHAZ—schizophrenia	2.66e-05	0.000165	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGA—schizophrenia	2.65e-05	0.000164	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—schizophrenia	2.65e-05	0.000164	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	2.64e-05	0.000164	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NPY—schizophrenia	2.64e-05	0.000164	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	2.64e-05	0.000164	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP26B1—schizophrenia	2.63e-05	0.000163	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR1B—schizophrenia	2.61e-05	0.000161	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—OXT—schizophrenia	2.61e-05	0.000161	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ERBB3—schizophrenia	2.6e-05	0.000161	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NPY—schizophrenia	2.58e-05	0.00016	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH4—schizophrenia	2.58e-05	0.00016	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ATP2A2—schizophrenia	2.58e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR1B—schizophrenia	2.55e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—OXT—schizophrenia	2.55e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—schizophrenia	2.52e-05	0.000156	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR1A—schizophrenia	2.51e-05	0.000155	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—schizophrenia	2.5e-05	0.000155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—OXT—schizophrenia	2.49e-05	0.000154	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR1B—schizophrenia	2.49e-05	0.000154	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NPS—schizophrenia	2.47e-05	0.000153	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	2.46e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR1A—schizophrenia	2.45e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2C—schizophrenia	2.42e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD1—schizophrenia	2.42e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NPS—schizophrenia	2.42e-05	0.00015	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—schizophrenia	2.41e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2C—schizophrenia	2.37e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD1—schizophrenia	2.37e-05	0.000147	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NPS—schizophrenia	2.36e-05	0.000146	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NTRK2—schizophrenia	2.36e-05	0.000146	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD3—schizophrenia	2.35e-05	0.000145	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TPH1—schizophrenia	2.34e-05	0.000145	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCLM—schizophrenia	2.34e-05	0.000145	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOE—schizophrenia	2.33e-05	0.000144	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD1—schizophrenia	2.32e-05	0.000144	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2C—schizophrenia	2.32e-05	0.000144	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NTRK2—schizophrenia	2.31e-05	0.000143	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOA1—schizophrenia	2.3e-05	0.000143	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD3—schizophrenia	2.3e-05	0.000142	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD4—schizophrenia	2.28e-05	0.000141	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NTRK2—schizophrenia	2.25e-05	0.00014	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD3—schizophrenia	2.24e-05	0.000139	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD4—schizophrenia	2.23e-05	0.000138	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ESR1—schizophrenia	2.22e-05	0.000138	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PRKD1—schizophrenia	2.2e-05	0.000136	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD4—schizophrenia	2.18e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CNR1—schizophrenia	2.18e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CNR1—schizophrenia	2.13e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR7—schizophrenia	2.12e-05	0.000131	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD2—schizophrenia	2.12e-05	0.000131	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CNR1—schizophrenia	2.08e-05	0.000129	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD2—schizophrenia	2.08e-05	0.000129	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR7—schizophrenia	2.08e-05	0.000129	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR7—schizophrenia	2.03e-05	0.000126	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD2—schizophrenia	2.03e-05	0.000126	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GSK3B—schizophrenia	2.02e-05	0.000125	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRL—schizophrenia	2e-05	0.000124	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRL—schizophrenia	1.96e-05	0.000121	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRL—schizophrenia	1.92e-05	0.000119	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—S100B—schizophrenia	1.87e-05	0.000116	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GAPDH—schizophrenia	1.84e-05	0.000114	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—S100B—schizophrenia	1.83e-05	0.000113	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CLOCK—schizophrenia	1.82e-05	0.000113	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—S100B—schizophrenia	1.79e-05	0.000111	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ERBB4—schizophrenia	1.79e-05	0.000111	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TPH2—schizophrenia	1.78e-05	0.00011	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CACNB2—schizophrenia	1.78e-05	0.00011	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ERBB4—schizophrenia	1.75e-05	0.000108	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DPYD—schizophrenia	1.75e-05	0.000108	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ERBB4—schizophrenia	1.71e-05	0.000106	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PLA2G4A—schizophrenia	1.68e-05	0.000104	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NRG1—schizophrenia	1.65e-05	0.000102	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	1.64e-05	0.000102	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MEF2C—schizophrenia	1.63e-05	0.000101	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CACNA1C—schizophrenia	1.62e-05	0.000101	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NRG1—schizophrenia	1.61e-05	9.99e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PLA2G4A—schizophrenia	1.61e-05	9.95e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MEF2C—schizophrenia	1.6e-05	9.9e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3C2A—schizophrenia	1.58e-05	9.8e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—YWHAZ—schizophrenia	1.58e-05	9.78e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NRG1—schizophrenia	1.58e-05	9.76e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MEF2C—schizophrenia	1.56e-05	9.68e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	1.54e-05	9.57e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ERBB3—schizophrenia	1.54e-05	9.56e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ERBB3—schizophrenia	1.51e-05	9.36e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—YWHAZ—schizophrenia	1.51e-05	9.35e-05	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—schizophrenia	1.49e-05	9.26e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—schizophrenia	1.49e-05	9.2e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ERBB3—schizophrenia	1.48e-05	9.15e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—schizophrenia	1.45e-05	9e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—schizophrenia	1.42e-05	8.8e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SNAP25—schizophrenia	1.42e-05	8.79e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—schizophrenia	1.38e-05	8.56e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOA1—schizophrenia	1.37e-05	8.46e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—schizophrenia	1.36e-05	8.4e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—schizophrenia	1.35e-05	8.37e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOA1—schizophrenia	1.34e-05	8.27e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EP300—schizophrenia	1.33e-05	8.22e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—schizophrenia	1.32e-05	8.18e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ESR1—schizophrenia	1.32e-05	8.17e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOA1—schizophrenia	1.31e-05	8.09e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ESR1—schizophrenia	1.29e-05	7.99e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP1A2—schizophrenia	1.28e-05	7.95e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TH—schizophrenia	1.27e-05	7.84e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ESR1—schizophrenia	1.26e-05	7.81e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GSK3B—schizophrenia	1.2e-05	7.41e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GSK3B—schizophrenia	1.17e-05	7.25e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GSK3B—schizophrenia	1.14e-05	7.09e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—COMT—schizophrenia	1.08e-05	6.66e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTP1—schizophrenia	1.07e-05	6.63e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOA—schizophrenia	1.07e-05	6.62e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCB1—schizophrenia	1.01e-05	6.28e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G4A—schizophrenia	9.84e-06	6.09e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—schizophrenia	9.84e-06	6.09e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—schizophrenia	9.49e-06	5.88e-05	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	8.87e-06	5.49e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—schizophrenia	8.7e-06	5.38e-05	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	8.68e-06	5.37e-05	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—schizophrenia	8.48e-06	5.25e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—schizophrenia	8.1e-06	5.01e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—schizophrenia	8.06e-06	4.99e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—schizophrenia	8.02e-06	4.96e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA1—schizophrenia	8e-06	4.96e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—schizophrenia	7.88e-06	4.88e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EP300—schizophrenia	7.87e-06	4.88e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—schizophrenia	7.71e-06	4.77e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EP300—schizophrenia	7.7e-06	4.77e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EP300—schizophrenia	7.53e-06	4.66e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—schizophrenia	5.64e-06	3.49e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—schizophrenia	5.51e-06	3.41e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—schizophrenia	5.39e-06	3.34e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—schizophrenia	4.76e-06	2.95e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—schizophrenia	4.66e-06	2.88e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EP300—schizophrenia	4.61e-06	2.86e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—schizophrenia	4.55e-06	2.82e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—schizophrenia	2.79e-06	1.73e-05	CbGpPWpGaD
